Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Chimeric Therapeutics Ltd C.CHM


Primary Symbol: CHMMF

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase 1B clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of NK and CAR NK assets with plans for Phase 1B clinical trials in solid tumors and blood cancers.


OTCPK:CHMMF - Post by User

Post by sleepydog1on Jan 20, 2021 5:05am
188 Views
Post# 32331525

Approvals

ApprovalsThey will be getting FDA approval very soon also and when that is announced this will be over a $1 ... Chris Wagner ceo of immunflex explains it all on the Chemistree Instagram stories ... search Chemistree then once on their page click on Immunoflex stories it's the 2nd one over can't miss it ... he is doing an interview in front of a beach by the ocean ... he explains many things but one of them is how easy and quick it is to get their product approved through Health Canada and FDA because of the classification of it being a natural health drug in Canada and classified a natural health supplement in the US which allows them to go from start up to on the market in less then 12 months opposed to being classified a pharmaceutical or vaccine which typically takes 8 to 10 years ... this is just the first inning here because FDA approval is coming next and then many drugs to follow which will all be approved in a short time frame and all are perfect drugs to increase the ability of our immune system to fight off covid naturally or any other pathogens that may follow .
<< Previous
Bullboard Posts
Next >>